On May 21, 2025, the 92nd National Pharmaceutical Trade Fair (referred to as the 'Pharmaceutical Fair'), an annual grand event in China's pharmaceutical industry, was grandly opened at the Guangzhou Canton Fair Complex. With the theme of 'Born for Newness,' the fair attracted over 2,000 pharmaceutical enterprises to participate." The Pharmaceutical Fair is one of the important professional events in China's pharmaceutical preparations and big health field. Founded in 1979, it is a long-standing, leading-scale, and widely influential pharmaceutical preparation exhibition in China, gathering pharmaceutical elites to forecast market trends, expand business ideas, discuss cutting-edge policies, and exchange practical experience.
Sichuan Xieli Pharmaceutical Co., Ltd. ("Xieli Pharma" for short) participated in the fair with its core products and innovative achievements, showcasing its technical achievements in green pharmaceuticals, international layout, and TCM modernization to global merchants, becoming one of the highlights of the exhibition. Established in the early 1980s, Xieli Pharma is a GMP-certified pharmaceutical enterprise focusing on the R&D and production of animal and plant (Chinese herbal medicine)-sourced drugs, specializing in Chinese herbal medicine cultivation, extraction of natural active ingredients, synthetic research and development of their derivatives, and production of active pharmaceutical ingredients (APIs), extracts, and intermediates.
Located in the API and Intermediates Zone (Booth No.: 11.2C35), Xieli Pharma systematically presented its R&D achievements in plant extracts and specialty APIs through product displays, technical explanations, and multimedia interactions. Its products are applied in pharmaceutical raw material supply, mainly including Rutin and Troxerutin series, flavonoid drugs Hesperidin and Diosmin series, Berberine hydrochloride and Baicalin series, Camptothecin and Irinotecan hydrochloride series of APIs and intermediates. These products have entered international markets in Europe, America, and Japan and comply with relevant regulatory requirements, with Xieli Pharma's technical strength attracting some domestic and foreign purchasers for negotiations.
As a national high-tech enterprise, Xieli Pharma continues to strive in TCM modernization. The refined TCM extraction production line management solutions highlighted at this exhibition, and innovative APIs through interdisciplinary technology integration, provide a case reference for improving resource utilization and international promotion of traditional medicinal materials.
At the exhibition site, Xieli Pharma demonstrated its commitment to green environmental protection and sustainable development with practical actions. As an active practitioner in the global health product raw materials field, the company leverages innovative achievements and refined process optimizations to reduce production energy consumption through process optimization and promote the application of sustainable production processes.
This participation not only showcased Xieli Pharma's strength through its core products and leading technologies but also conveyed the company's deep understanding and active practice of social responsibility through its corporate culture and environmental philosophy. At the conclusion of the exhibition, the company's team demonstrated profound professional qualities in every link of the orderly dismantling work with a professional and efficient working attitude, adding more luster to the corporate image.
On the first day of the Fair, Xieli Pharma reached strategic cooperation agreements on API supply with several well-known domestic pharmaceutical enterprises. The Pharmaceutical Fair is not only a window for product display but also a key platform for gaining insight into industry trends and connecting global resources. We will continue to increase strategic investments, promote the high-quality development of China's pharmaceutical industry with the concept of "green pharmaceuticals." This layout not only responds to the global pharmaceutical industry's demand for green development but also provides a practical path for building a greener and more resilient industrial ecosystem.
